Lorena Di Pietro - Concepedia

Author

Lorena Di Pietro

Università Cattolica del Sacro Cuore ORCID

Also Known As

Di Pietro, L., Di Pietro, Lorena, L. Di Pietro, Lorena Di Pietro, P. Laneve

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Università Cattolica del Sacro Cuore Agostino Gemelli University Polyclinic Istituti di Ricovero e Cura a Carattere Scientifico Institute for Complex Systems Fondazione Poliambulanza Istituto Ospedaliero

About

Lorena Di Pietro is an author at Università Cattolica del Sacro Cuore specializing in medicine, developmental biology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	605
2	Engineering	2	2	73
3	Biomedical Engineering	2	2	73
4	Public Health	1	1	41
5	Biostatistics	1	1	41

Lorena Di Pietro

Publications

843

Citations

H-Index

Page 1

	Year	Citations
De novo mutations in ATP1A3 cause alternating hemiplegia of childhood Erin L. Heinzen, Kathryn J. Swoboda, Yuki Hitomi, Nature Genetics Rare DiseasesMendelian DisorderGenetic DisorderGeneticsPathology	2012	417
Potential therapeutic targets for ALS: MIR206, MIR208b and MIR499 are modulated during disease progression in the skeletal muscle of patients Lorena Di Pietro, Mirko Baranzini, Maria Grazia Berardinelli, Scientific Reports	2017	53
Schizophrenia and Human Self-Domestication: An Evolutionary Linguistics Approach Antonio Benítez‐Burraco, Lorena Di Pietro, Marta Barba, Brain Behavior and Evolution	2017	49
Reduction and shaping of graphene-oxide by laser-printing for controlled bone tissue regeneration and bacterial killing Valentina Palmieri, Marta Barba, Lorena Di Pietro, 2D Materials Tissue EngineeringEngineeringBiomaterials DesignBiofabricationBiomedical Engineering	2017	45
Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study Francesco Danilo Tiziano, Rosa Lomastro, Lorena Di Pietro, European Journal of Human Genetics Genetic EpidemiologyMolecular Cross-sectional StudyBiomarkersDegenerative DiseaseBiostatistics	2012	41
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: results of a phase IIb double-blind study of salbutamol Francesco Danilo Tiziano, Rosa Lomastro, Emanuela Abiusi, Journal of Medical Genetics	2018	39
INSIDIA 2.0 High-Throughput Analysis of 3D Cancer Models: Multiparametric Quantification of Graphene Quantum Dots Photothermal Therapy for Glioblastoma and Pancreatic Cancer Giordano Perini, Enrico Rosa, Ginevra Friggeri, International Journal of Molecular Sciences EngineeringSpheroid DisruptionCancer SpheroidsBiomedical EngineeringMolecular Graphic	2022	28
GLI1 and AXIN2 Are Distinctive Markers of Human Calvarial Mesenchymal Stromal Cells in Nonsyndromic Craniosynostosis Lorena Di Pietro, Marta Barba, Chiara Prampolini, International Journal of Molecular Sciences	2020	27
Gain-of-function variants and overexpression of RUNX2 in patients with nonsyndromic midline craniosynostosis Araceli Cuellar, Krithi Bala, Lorena Di Pietro, Bone SclerostinDevelopmental BiologySpinal Cord InjuryCraniofacial DisorderCraniofacial Development	2020	23
Effects of Class II-Selective Histone Deacetylase Inhibitor on Neuromuscular Function and Disease Progression in SOD1-ALS Mice Daniela Buonvicino, Roberta Felici, Giuseppe Ranieri, Neuroscience Neurodegenerative DiseasesAmyotrophic Lateral SclerosisDisease ProgressionMedicinePharmacology	2018	22

Page 1